Prevalence of fatal adverse drug reactions in hospitalized patients
Adult
Aged, 80 and over
Male
Drug-Related Side Effects and Adverse Reactions
Anti-Inflammatory Agents, Non-Steroidal
Hemorrhage
Middle Aged
3. Good health
Young Adult
03 medical and health sciences
0302 clinical medicine
Fibrinolytic Agents
Risk Factors
Cause of Death
Prevalence
Adverse Drug Reaction Reporting Systems
Humans
Female
Hospital Mortality
Registries
Aged
Retrospective Studies
DOI:
10.5414/cpp47596
Publication Date:
2011-03-25T04:16:41Z
AUTHORS (5)
ABSTRACT
The aims of the present study were to assess the prevalence of fatal adverse drug reactions (FADRs) in a hospitalized population, identify the drugs involved and investigate reported risk factors for these events.The study population of this retrospective, single-centre case study comprised 289 patients dying between 1 January 2004 and 31 December 2004 and registered in the Cause of Death Register of a teaching hospital. All compiled data were recorded by two observers especially trained to identify and report adverse drug reactions (ADRs). The degree of probability that the ADR led directly to death was determined by using WHO criteria and an adapted version of Naranjo's score.Among 289 deceased study subjects, 17 (5.9%) were suspected to have died from an ADR. The most common suspected FADRs were gastrointestinal hemorrhages (52.9%), central nervous system hemorrhages (17.6%), cardiac disorders (17.6%), drug-induced myelosuppression (6%) and antimicrobial-related enterocolitis (6%). The drugs most frequently implicated in a FADR were antithrombotic drugs (65%), nonsteroidal anti-inflammatory drugs (NSAIDs) (47%) and corticosteroids (29%). The only risk factors associated with FADRs in this population were multiple-drug therapy and the presence of platelet antiaggregants and NSAIDs, alone or associated.FADRs are an important cause of death in hospitalized patients. Hemorrhages were seen in a majority of the fatal reactions, and antithrombotic agents or NSAIDs were implicated in most of these events.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (25)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....